Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
Brivaracetam is a newer antiseizure medication than levetiracetam. It has a more selective action on the synaptic vesicle glycoprotein 2A binding site, and it seems to provide a more favorable neuropsychiatric profile. The aim of this study was to assess the safety and tolerability of an overnight s...
| Published in: | Epilepsy & Behavior Reports |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-01-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589986421000782 |
